GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (OTCPK:MEPTF) » Definitions » EV-to-FCF

Medipost Co (Medipost Co) EV-to-FCF : -36.86 (As of Jun. 11, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Medipost Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medipost Co's Enterprise Value is $636.72 Mil. Medipost Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was $-17.28 Mil. Therefore, Medipost Co's EV-to-FCF for today is -36.86.

The historical rank and industry rank for Medipost Co's EV-to-FCF or its related term are showing as below:

MEPTF' s EV-to-FCF Range Over the Past 10 Years
Min: -1756.05   Med: -32.16   Max: 254.15
Current: -3.69

During the past 13 years, the highest EV-to-FCF of Medipost Co was 254.15. The lowest was -1756.05. And the median was -32.16.

MEPTF's EV-to-FCF is ranked worse than
100% of 384 companies
in the Biotechnology industry
Industry Median: 8.31 vs MEPTF: -3.69

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-11), Medipost Co's stock price is $44.99. Medipost Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.000. Therefore, Medipost Co's PE Ratio for today is N/A.


Medipost Co EV-to-FCF Historical Data

The historical data trend for Medipost Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipost Co EV-to-FCF Chart

Medipost Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 109.70 236.83 -82.83 -48.20 -18.98

Medipost Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.28 -10.95 -3.91 -6.11 -4.35

Competitive Comparison of Medipost Co's EV-to-FCF

For the Biotechnology subindustry, Medipost Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medipost Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medipost Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Medipost Co's EV-to-FCF falls into.



Medipost Co EV-to-FCF Calculation

Medipost Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=636.716/-17.276
=-36.86

Medipost Co's current Enterprise Value is $636.72 Mil.
Medipost Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-17.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medipost Co  (OTCPK:MEPTF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Medipost Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=44.99/0.000
=N/A

Medipost Co's share price for today is $44.99.
Medipost Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Medipost Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Medipost Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Medipost Co (Medipost Co) Business Description

Traded in Other Exchanges
Address
21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR
Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (Medipost Co) Headlines

No Headlines